Market Newsdesk

NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Beyond Meat, Inc. (“Beyond Meat” or the “Company”) (NASDAQ: BYND) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Beyond Meat investors who were adversely affected by alleged securities fraud between May 5, 2020 and October 13, 2022. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/beyond-meat-lawsuit-submission-form?prid=40973&wire=3

BYND investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: According to the complaint, throughout the Class Period defendants made numerous materially false and misleading statements and omissions concerning the Company’s ability to produce plant-based meats at scale. Specifically, defendants repeatedly assured investors that Beyond Meat conducted “extensive testing” to “ensure manufacturability” of its plant-based meat products at commercial scale, and touted the success of the Company’s product tests with its large-scale partnerships as “very positive.” Further, defendants blamed any delays in launching these large-scale partnerships on Covid-19.

WHAT’S NEXT? If you suffered a loss in Beyond Meat during the relevant time frame, you have until July 10, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 4th Floor Suite #427
New York, NY 10006
[email protected] 
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com 

NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in The Walt Disney Company (“Disney” or the “Company”) (NYSE: DIS) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Disney investors who were adversely affected by alleged securities fraud between December 10, 2020 and November 8, 2022. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/disney-lawsuit-submission-form?prid=40975&wire=3

DIS investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (a) Disney+ was suffering decelerating subscriber growth, losses, and cost overruns; (b) the true costs incurred in connection with Disney+ had been concealed by Disney executives by debuting certain content intended for Disney+ initially on Disney’s legacy distribution channels and then making the shows available on Disney+ thereafter in order to improperly shift costs out of the Disney+ segment; (c) Disney Media and Entertainment Distribution had made platform distribution decisions based not on consumer preference, consumer behavior, or the desire to maximize the size of the audience for the content as represented, but based on the desire to hide the full costs of building Disney+’s content library; (d) the Company was not on track to achieve its 2024 Disney+ paid global subscriber and profitability targets, that such targets were not achievable, and that such estimates lacked a reasonable basis in fact; and (e) as a result of (a)-(d) above, defendants had materially misrepresented the actual performance of Disney+, the sustainability of Disney+’s historical growth trends, the profitability of Disney+, and the likelihood that Disney could achieve its 2024 Disney+ subscriber and profitability targets.

WHAT’S NEXT? If you suffered a loss in Disney during the relevant time frame, you have until July 11, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 4th Floor Suite #427
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Horizon Bancorp, Inc. (“Horizon” or the “Company”) (NASDAQ: HBNC) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Horizon investors who were adversely affected by alleged securities fraud between March 9, 2022 and March 10, 2023. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/horizon-lawsuit-submission-form?prid=40965&wire=3

HBNC investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) the Company maintained deficient internal accounting controls relating to its classification of certain loan balances and securities; (ii) as a result of the foregoing deficiencies, throughout 2022 the Company issued quarterly financial statements containing errors that would require subsequent revision; (iii) restatement of the foregoing financial statements would hinder the Company’s ability to timely file its annual report for 2022; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

WHAT’S NEXT? If you suffered a loss in Horizon during the relevant time frame, you have until June 20, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 4th Floor Suite #427
New York, NY 10006
[email protected] 
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Trinseo PLC (“Trinseo” or the “Company”) (NYSE: TSE) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Trinseo investors who were adversely affected by alleged securities fraud between May 3, 2021 and March 27, 2023. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/trinseo-plc-lawsuit-submission-form?prid=40964&wire=3

TSE investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) the Company’s Bristol, Pennsylvania plant had a troubled safety record while under prior ownership and continued to be unsafe after the Company acquired it; (2) defendants did not sufficiently disclose specific risks related to conducting operations at that plant; (3) operating a chemical plant with an unsafe history and presently unsafe operations exposed the Company to a heightened risk of a chemical spill or other adverse events; and (4) as a result, defendants statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.

WHAT’S NEXT? If you suffered a loss in Trinseo during the relevant time frame, you have until June 20, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 4th Floor Suite #427
New York, NY 10006
[email protected] 
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com 

NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in LivePerson, Inc. (“LivePerson” or the “Company”) (NASDAQ: LPSN) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of LivePerson investors who were adversely affected by alleged securities fraud between May 10, 2022 and March 16, 2023. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/liveperson-lawsuit-submission-form?prid=40966&wire=3

LPSN investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) LivePerson failed to address any material weaknesses with internal controls; (2) LivePerson’s third quarter financial statements, ended in September 30, 2022 failed to disclose its subsidiary, WildHealth’s, suspension of Medicare reimbursement; (3) as a result, LivePerson’s fourth quarter 2022 revenue would be affected; and (4) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

WHAT’S NEXT? If you suffered a loss in LivePerson during the relevant time frame, you have until June 23, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 4th Floor Suite #427
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Fulcrum Therapeutics, Inc. (“Fulcrum” or the “Company”) (NASDAQ: FULC) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fulcrum investors who were adversely affected by alleged securities fraud between March 3, 2022 and March 8, 2023. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/fulcrum-lawsuit-submission-form?prid=40968&wire=3

FULC investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) the preclinical data submitted in support of FTX-6058 (an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies) showed safety concerns regarding potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would place a clinical hold on preclinical studies of FTX-6058; (iii) accordingly, the Company had overstated FTX-6058’s clinical and/or commercial prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

WHAT’S NEXT? If you suffered a loss in Fulcrum during the relevant time frame, you have until June 27, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 4th Floor Suite #427
New York, NY 10006
[email protected] 
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com 

ATLANTA, June 19, 2023 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors that a class action lawsuit has been filed against Viatris Inc. (“Viatris,” or “the Company”) (NASDAQ: VTRS). The lawsuit alleges Viatris made materially false and/or misleading statements and/or failed to disclose material adverse facts about the Company’s business, operations, and prospects, including: (i) the Company was experiencing significantly more competition in its United States complex generics business than disclosed; (ii) the Company was not able to effectively manage its base business erosion or create a stable revenue base; (iii) despite being one of the Company’s only growth drivers, Viatris was actively planning to divest its biosimilars business in order to secure enough cash to let it purportedly meet its phase one goals; (iv) Viatris was deviating from the business model it touted through the Class Period and undertaking a significant global reshaping of its business which would undermine its ability to achieve stable revenue growth; and (v) the Company was anticipating less financial growth moving into 2022.

If you bought shares of Viatris between March 1, 2021 and February 25, 2022, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at [email protected] or Joshua Karr, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website https://holzerlaw.com/case/viatris/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is July 14, 2023.

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021 and 2022, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.  

CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
[email protected]

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., June 19, 2023 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced that the Company will present in a fireside chat at the TD Cowen Radiopharmaceutical Innovation Summit on Tuesday, June 20, 2023 at 12:00 p.m. ET. Presenting on behalf of Molecular Partners will be Patrick Amstutz, Chief Executive Officer, and Daniel Steiner, SVP Research.  

A live webcast of the event will be available on the “News and Events” page in the “Events” section of the Company’s website. A replay of the webcast will be archived on the Company’s website for 1 year following their respective presentation dates.

About Molecular Partners AG  
Molecular Partners AG is a clinical-stage biotech company developing DARPin (designed ankyrin repeat protein) therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics in the areas of oncology and virology and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas. www.molecularpartners.com Find us on Twitter – @MolecularPrtnrs

For further details, please contact:

Seth Lewis, Investor Relations
[email protected]
Tel: +1 781 420 2361

Antonio Ligi, Communications
Zurich-Schlieren, Switzerland
[email protected]
Tel: +41 79 723 36 81

HUNTSVILLE, Ala., June 19, 2023 (GLOBE NEWSWIRE) — Aerojet Rocketdyne has successfully completed the qualification static fire test of the eSR-19, the advanced large solid rocket motor that will power the Missile Defense Agency’s (MDA) next generation Medium Range Ballistic Missile (MRBM) target used to test our nation’s missile defense systems.

“I applaud the dedicated efforts by teams across Aerojet Rocketdyne to meet this important milestone,” said Eileen P. Drake, Aerojet Rocketdyne CEO and president. “Our steadfast workforce and advanced solid rocket motor propulsion remain crucial to helping protect our nation and our allies.”

The successful qualification test, conducted by Air Force Research Laboratory (AFRL) and Aerojet Rocketdyne personnel at AFRL’s test facility at Edwards Air Force Base, California, paves the way for delivery of flight test motors later this year.

The eSR-19 is a redesigned version of the SR-19 that currently serves as the second stage of the nation’s Minuteman III strategic missiles. Featuring a lighter, filament-wound composite case and other performance-enhancing improvements, the eSR-19 will provide the propulsion for both stages of MDA’s air-launched, medium-range target vehicle, developed by Aerojet Rocketdyne subsidiary Coleman Aerospace.

The motor was designed and fabricated in Aerojet Rocketdyne facilities in Huntsville, Alabama, and cast and cured in Camden, Arkansas. The eSR-19 motors are later integrated into the target systems by the Coleman Aerospace team in Orlando, Florida.

This recent qualification test was the latest achievement in the evolution of Aerojet Rocketdyne’s legacy Large Solid Rocket Motor (LSRM) capabilities, which have included investments in a talented workforce and new modern LSRM facilities.

About Aerojet Rocketdyne: Aerojet Rocketdyne, a subsidiary of Aerojet Rocketdyne Holdings, Inc. (NYSE:AJRD), is a world-recognized aerospace and defense leader that provides propulsion systems and energetics to the space, missile defense and strategic systems, and tactical systems areas, in support of domestic and international customers. For more information, visit www.Rocket.com and www.AerojetRocketdyne.com. Follow Aerojet Rocketdyne and CEO Eileen Drake on Twitter at @AerojetRdyne and @DrakeEileen.

Media Contact:

Eileen Lainez, Aerojet Rocketdyne, 571-239-7839
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f16ff1b8-ba9b-4397-9cbb-f9e733d5f27d

 

ATLANTA, June 19, 2023 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC informs investors that it has filed a class action lawsuit against TriplePoint Venture Growth BDC Corp. (“TriplePoint,” or the “Company”) (NYSE: TPVG). The lawsuit alleges TriplePoint made materially false and/or misleading statements and/or failed to disclose material adverse facts, including: (i) TriplePoint had overstated the strength of its various portfolio companies and loan book, as well as the viability of its overall investment strategy; (ii) the foregoing, once revealed, was likely to have a material negative impact on the Company’s financial position and/or prospects; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

If you bought shares of TriplePoint between March 4, 2020 and May 1, 2023, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. [email protected] or Joshua Karr, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website www.holzerlaw.com/case/triplepoint/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is August 15, 2023.

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021 and 2022, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.  

CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
[email protected]